Pharm
Methylphenidate
search
Methylphenidate
, Ritalin, Methylin, Concerta, Focalin, Metadate, Quillivant, Daytrana
See Also
Attention Deficit Disorder in Children
School Problem Evaluation
Attention Deficit Disorder in Adults
ADHD Diagnosis
ADHD Differential Diagnosis
ADHD Comorbid Conditions
ADHD Non-Pharmacologic Management
ADHD Medication
s
Dextroamphetamine
(
Dexedrine
,
Dextrostat
,
Adderall
) or
Lisdexamfetamine
(
Vyvanse
)
Atomoxetine
(
Strattera
)
Indications
Methylphenidate (Ritalin)
Attention Deficit Hyperactivity Disorder
(
ADHD
)
Narcolepsy
Depression in medically ill elderly patients
Enhanced pain control in patients on
Opiate
s
Contraindications
See
Drug Interaction
s below
Congenital Heart Defect
(ask related PMH,
Family History
and screen on
ADHD
exam)
Consider an EKG before prescribing
Vetter (2008) Circulation 117(18):2407-23. [PubMed]
Motor Tic
s or
Tourette's Syndrome
Glaucoma
Seizure Disorder
Hypertension
Pregnancy
Mechanism
See
ADHD Medication
As with other
Amphetamine
-like drugs, Methylphenidate triggers release of biogenic amines
Norepinephrine
,
Dopamine
and
Serotonin
are released from storage
Vesicle
s
Effects
CNS Stimulation
Inhibits fast-rate behavior in hyperkinetic, hyperactive children
Speeds slow-rate behavior (e.g. improves memory and learning)
Decreases appetite
Ergogenic Aid
in athletes (illicit use)
Precautions
See
ADHD Medication
for overall approach and medication selection
Maximum Dosing
Adults and older adolescents (>50 kg) may in some cases need dosing in excess of listed maximum
Exercise
caution and
Informed Consent
as these doses are not FDA approved
Exceed the manufacturers recommendation
Absolute maximum doses
Methylphenidate: 100 mg per day in divided doses
Concerta 108 mg per day
(2013) Presc Lett 20(9): 50-1
Pharmacokinetics
Methylphenidate
Immediate Release: Ritalin-IR, Methylin IR
Onset of action: within 20 to 30 minutes of dose (up to 60 minutes)
Peaks at 1.9 hours on average
Duration: 3 to 6 hours
Immediate Release: Focalin (Dexmethylphenidate)
D-isomer of Ritalin (l-isomer is inactive)
Prescribed at half dose of Ritalin
Same
Pharmacokinetics
as immediate release Methylphenidate
Fewer
Headache
s but more
Stomach
e pain than with Methylphenidate
Long-Acting: Ritalin-LA
Duration: 8 hours
Biphasic release
Immediate release: 50%
Modified release beads: 50%
Preferred over Ritalin SR
Long-Acting: Ritalin-SR, Metadate ER, Methylin ER
Onset of action: within 90 minutes of dose
Peaks at 3 hours on average
Duration: 5-8 hours (gradual decrease after 3 hours)
Less effective than Ritalin IR twice daily
Other sustained release forms are preferred
Very-Long-Acting: Concerta
Onset of action: within 60 to 120 minutes of dose
Duration: 12 hours
Comparable to Ritalin-IR three times daily
Very-Long-Acting: Metadate-CD
Flat concentration curve despite biphasic release
Duration: 8-10 hours
Biphasic peaks at 1.5 hours and again at 4.5 hours
Immediate release beads: 30%
Extended release beads: 70%
Very-Long Acting: Quillivant XR
Combination of Immediate release Methylphenidate (20%) and extended release Methylphenidate (80%)
Peaks at 5 hours
Duration: 12 hours
Niche is that it is suspension (compounded by pharmacy) at 5 mg/ml
Other stimulant capsules can be sprinkled on apple sauce (Focalin XR, Metadate CD, Ritalin LA,
Adderall
XR)
References
(2013) Presc Lett 20(2): 8-9
Dosing
Children (over age 6 years)
Maximum total daily dose: 60 mg/day
Immediate Release: Methylphenidate
Usual Range: 0.5 - 1 mg/kg/day
Start: 2.5 to 5 mg per dose, twice daily
Initial Schedule (lasts 4 hours - dose up to 4 times daily)
Morning: 2.5 to 5 mg PO 30 minutes before breakfast
Noon: 2.5 to 5 mg PO 30 minutes before lunch
Afternoon: 1.25 to 2.5 mg PO at 3-4 pm
Titrate dose up weekly
Increase dose by 0.1 mg/kg/dose (or 5-10 mg/day)
Maximum dose: 2 mg/kg/day or 60 mg/day (some sources suggest maximum up to 90)
Immediate Release: Focalin (Dexmethylphenidate)
Start: 2.5 mg orally twice daily
Usual Dose: 5-10 mg orally twice daily
Maximum Dose: 20 mg orally daily
Sustained Release
Concerta 18 to 54 mg orally daily
Start: 18 mg qAM
May increase weekly by 18 mg/day
Conversions
Ritalin 5 mg or 20 mg SR: Concerta 18 mg
Ritalin 10 mg or 40 mg SR: Concerta 36 mg
Ritalin 15 mg or 60 mg SR: Concerta 54 mg
Maximum: 72 mg/day
Ritalin LA or Metadate CD
Start: 20 mg orally daily
May increase weekly by 10-20 mg/day
Usual dose: 20-40 mg orally once daily
Maximum: 60 mg/day
Ritalin-SR (Other long-acting agents are preferred)
Dose: 0.6 to 2 mg/kg up to 20-40 mg orally daily
Dose is directly converted from Regular Ritalin
Conversion to Ritalin SR (Metadate ER, Methylin ER)
Administer cumulative 8 hour regular dose
Example: Conversion
Child takes Ritalin 10 mg, 5 mg, and 5 mg
Ritalin SR dosing will be 20 mg qAM
Example: Schedule
Morning: 20-40 mg orally
Early afternoon: 20 mg orally
Daytrana (Methylphenidate patch)
Start: 10 mg patch worn 9 hours daily
Max: 30 mg patch worn 9 hours daily
Skin irritation or rash may occur
Dosing
Adults with
ADHD
or
Narcolepsy
Maximum total daily dose: 90 mg
Regular Release: 5 to 20 mg PO bid to tid at meals
Sustained Release: 20 mg PO up to q8 hours
Dosing
Elderly with comorbid Depression
Maximum total daily dose: 30 mg
Regular Release: 5 to 10 mg bid to tid
Management Difficulty Swallowing Medication - Long Acting Methylphenidate
Gene
ric
Ritalin LA
Metadate CD Sprinkle caps
Trade Name - Expensive ($300/month)
Aptensio XR spinkle caps (lasts 12 hours)
QuilliChew ER chewable 20 and 40 mg tabs (lasts 8-13 hours)
Quillavant XR Suspension 5 mg/ml (lasts 12 hours)
Adhansia XR (lasts 13 hours)
Jornay PM (taken at night and peaks 14 hours later, the next morning)
Contempla XR 17.3 mg dissolving tablets (lasts 12 hours)
Daytrana Transdermal
Patch
10 mg (lasts 10-12 hours)
References
(2016) Presc Lett 23(3):16
Drug Interactions
Avoid concurrent
Decongestant
use
Avoid within 14 days of
MAO Inhibitor
Safety
Pregnancy Category C
Unknown safety in
Lactation
Monitoring
Each Visit
Height
Weight
Blood Pressure
Pulse
Adverse Effects
See
ADHD Medication
References
(2002) Lexicomp Drug Database
(1996) Pediatrics 98:301-4 [PubMed]
Andesman (1999) Pediatr Clin North Am 46:945-63 [PubMed]
Bennett (1999) Pediatr Clin North Am 46:929-44 [PubMed]
Challman (2000) Mayo Clin Proc 75:711-21 [PubMed]
Chang (2020) Am Fam Physician 102(10):592-602 [PubMed]
Pliszka (2007) J Am Acad Child Adolesc Psychiatry 46(7):894-921 [PubMed]
http://www.jaacap.com/article/S0890-8567(09)62182-1/fulltext
Type your search phrase here